Free Trial

GRI Bio (GRI) Earnings Date, Estimates & Call Transcripts

GRI Bio logo
$1.44 +0.14 (+10.77%)
As of 04:00 PM Eastern

GRI Bio Earnings Summary

GRI Bio released Q2 2025 earnings on August 12, 2025, reporting an EPS of -$1.31, which met the consensus estimate of -$1.31. With a trailing EPS of -$11.56, GRI Bio's earnings are expected to grow next year, from ($3.04) to ($0.90) per share.

Latest Q2
Earnings Date
Aug. 12Estimated
Consensus EPS
(Aug. 12)
-$1.31
Actual EPS
(Aug. 12)
-$1.31

Q2 2025 Earnings Resources

Get GRI Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GRI Bio and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

GRI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GRI Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20251-$1.39-$1.39-$1.39
Q3 20251-$0.75-$0.75-$0.75
Q4 20251-$0.22-$0.22-$0.22

GRI Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025-$1.31-$1.31--$1.31--
5/15/2025Q1 2025-$4.08-$5.80 -$1.72-$5.80--
8/13/2024Q2 2024--$83.64--$4.92--
5/10/2024Q1 2024--$101.66--$0.46--
11/14/2023Q3 2023--$804.44--$0.52--
8/14/2023Q2 2023--$4,316.13--$2.79--

GRI Bio Earnings - Frequently Asked Questions

GRI Bio (NASDAQ:GRI) last announced its quarterly earning data on Tuesday, August 12, 2025. Learn more on GRI's earnings history.

In the previous quarter, GRI Bio (NASDAQ:GRI) reported ($1.31) earnings per share (EPS) to hit the analysts' consensus estimate of ($1.31). Learn more on analysts' earnings estimate vs. GRI's actual earnings.

GRI Bio's earnings report can be found in their filing with the SEC.
View SEC filing

GRI Bio (NASDAQ:GRI) has a recorded net income of -$8.21 million. GRI has generated -$11.56 earnings per share over the last four quarters.

GRI Bio's earnings are expected to grow from ($3.04) per share to ($0.90) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:GRI) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners